{
  "slug": "medical-metree",
  "name": "Medical Metree",
  "description": "MeTree is a web-based, patient-facing tool developed by Duke Center for Applied Genomics & Precision Medicine. It collects comprehensive personal and family health history, including lifestyle data, and provides clinical decision support to patients and providers for a wide range of conditions like various cancers, hereditary cancer syndromes, and cardiovascular diseases. Its aim is to improve cancer screening rates, risk management, and enhance the provider-patient relationship by providing rich, standardized data.",
  "url": "https://optimly.ai/brand/medical-metree",
  "websiteUrl": null,
  "logoUrl": "https://logo.clearbit.com/https://medschool.duke.edu/blog/metree-software-recommended-presidents-cancer-panel",
  "baiScore": 53,
  "bai_tier_status": "active",
  "bai_score_status": "active",
  "archetype": "Challenger",
  "archetype_status": "active",
  "category": "Healthcare",
  "categorySlug": null,
  "keyFacts": [],
  "aiReadiness": [],
  "competitors": [],
  "competitorsProse": null,
  "inboundCompetitors": [],
  "aiAlternatives": [],
  "parentBrand": null,
  "subBrands": [],
  "updatedAt": "2026-07-26T00:02:47.505Z",
  "verifiedVitals": {
    "website": "https://precisionmedicine.duke.edu/researchers/precision-medicine-programs/risk-assessment/family-history/metree-software",
    "founded": "2012",
    "headquarters": "Duke Center for Applied Genomics & Precision Medicine, Duke University, Durham, NC",
    "pricing_model": "Not explicitly detailed. Given its development within a university research setting, it likely operates on a licensing, partnership, or grant-funded model for integration into healthcare systems.",
    "core_products": "MeTree, a web-based patient-facing tool for family and personal health history collection and clinical decision support.",
    "key_differentiator": "MeTree's key differentiators include its recommendation by the President's Cancer Panel, its ability to collect comprehensive patient data beyond standard EMRs, its calculation of multiple clinical risk scores (Gail, BRCApro, Framingham), and its provision of clinical decision support for a wide array of cancers and other medical conditions. Its adaptability and ongoing efforts to scale to diverse healthcare settings also set it apart.",
    "target_markets": "Healthcare providers, clinical settings (especially primary care), national cancer programs, patients requiring comprehensive cancer screening and risk assessment, and institutions focused on precision medicine and genomics.",
    "employee_count": "Not specified, developed by a team of researchers at Duke University.",
    "funding_stage": "Funded as part of the National Human Genome Research Institute’s (NHGRI) IGNITE (Implementing Genomics in Clinical Practice) network.",
    "subcategory": "Clinical Decision Support"
  },
  "intentTags": {
    "problemIntents": [
      "Manual Family History Collection: Healthcare providers manually collect family and personal health history during patient visits, often resulting in incomplete or unstandardized data, and lacking auto",
      "Healthcare IT Consulting & Integration: Hiring specialized agencies or consultants to integrate existing, less specialized health IT systems or customize EMRs to attempt to capture similar data, witho",
      "Maintain Status Quo in Screening and Risk Assessment: Continuing with current, potentially inadequate, cancer screening and risk assessment protocols, leading to missed opportunities for early detecti"
    ],
    "solutionIntents": [
      "MeTree software President's Cancer Panel",
      "Duke MeTree family health history tool",
      "Clinical decision support cancer screening genomics",
      "Generic EMR Systems: Relying solely on standard Electronic Medical Record (EMR) systems that may have basic health history fields but typically lack the depth of personal and family history, lifestyle"
    ],
    "evaluationIntents": []
  },
  "timestamp": 1785296593171
}